Department of Clinical Psychology, Center for Anxiety and Related Disorders, Boston University, 648 Beacon Street, 6th Floor, Boston, MA 02215, USA.
Depress Anxiety. 2009;26(10):909-16. doi: 10.1002/da.20607.
The current Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) specifies that generalized anxiety disorder (GAD) should not be diagnosed if it occurs exclusively during an episode of a major depressive disorder (MDD) or another mood disorder. This hierarchy rule was intended to promote diagnostic parsimony, but may result in the loss of important clinical information. The goal of this study was to compare individuals with MDD, comorbid MDD and GAD, and GAD within the course of MDD at intake and 12-month follow-up on self-report measures, clinician ratings, and rates of comorbidity.
Participants were divided into three diagnostic groups: MDD without GAD (n=124), comorbid MDD and GAD (n=59), and GAD within the course of MDD (n=166). All the participants completed a semi-structured clinical interview and self-report measures assessing psychopathology, temperament, and functional impairment. A subset of the total sample completed a follow-up assessment of 12 months postintake.
Individuals with comorbid MDD and GAD and GAD within the course of MDD reported more psychopathology, negative affect, and functional impairment at intake than individuals with MDD only. The presence of GAD at intake, however, did not differentially predict symptom severity, functional impairment, or the presence of comorbidity at 12-month follow-up.
Cross-sectional findings indicate that individuals with GAD within the course of MDD experience levels of psychopathology, functional impairment, and comorbidity similar to those found in individuals with comorbid GAD and MDD. Preliminary longitudinal findings, however, suggest that the presence of GAD in patients with MDD does not have prognostic significance.
当前的《精神障碍诊断与统计手册》(DSM-IV-TR)规定,如果广泛性焦虑障碍(GAD)仅发生在重性抑郁障碍(MDD)或其他心境障碍发作期间,则不应诊断为 GAD。这种层次规则旨在促进诊断的简约,但可能导致重要临床信息的丢失。本研究的目的是比较在入组时和 12 个月随访时,以自评量表、临床医生评定和共病率为指标,比较患有 MDD、共病 MDD 和 GAD 以及在 MDD 病程中出现 GAD 的个体。
参与者分为三组:无 GAD 的 MDD(n=124)、共病 MDD 和 GAD(n=59)和在 MDD 病程中出现 GAD(n=166)。所有参与者都完成了半结构化临床访谈和自评量表,评估精神病理学、气质和功能障碍。总样本的一部分完成了入组后 12 个月的随访评估。
共病 MDD 和 GAD 以及在 MDD 病程中出现 GAD 的个体在入组时报告的精神病理学、负性情绪和功能障碍比仅有 MDD 的个体更多。然而,入组时存在 GAD 并不能预测 12 个月随访时的症状严重程度、功能障碍或共病的存在。
横断面研究结果表明,在 MDD 病程中出现 GAD 的个体经历的精神病理学、功能障碍和共病程度与共病 GAD 和 MDD 的个体相似。然而,初步的纵向研究结果表明,在 MDD 患者中存在 GAD 并无预后意义。